Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia

被引:49
作者
Manar M.H. [1 ]
Brown M.R. [2 ]
Gauthier T.W. [1 ]
Brown L.A.S. [1 ]
机构
[1] Div. of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta
[2] Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta
基金
美国国家卫生研究院;
关键词
D O I
10.1038/sj.jp.7211020
中图分类号
学科分类号
摘要
Objective: Reactive oxygen species (ROS) contribute to oxidative lung injury. The glutathione-S-transferases (GST) family and microsomal epoxide hydrolase (mEPHx) enzymes detoxify, ROS, and genetic polymorphisms alter this detoxification. We hypothesized that polymorphisms encoding for less efficient enzymes were associated with bronchopulmonary dysplasia (BPD). Study Design: We determined allelic distribution of these polymosphisms in a pilor study of 35 BPD cases and 98 controls. χ2 and regression analysis were performed. Results: GST P1 val105ile distribution differed between the groups, with the more efficient val/val alle predominately in controls (p≤0.05). When controlling for race and sex. BPD cases were less likely to be homozygotes for the val/val isoform (OR 0.21, CI: 0.045-0.95, p = 0.04) and more likely to possess the less efficient ile isoform (OR 4.5, CI: 1.0-20.7, p = 0.05). Conclusions: The pilot study suggests that BPD is associated with the presence of the GST-P1 105ile alle. Future prospective studies are warranted.
引用
收藏
页码:30 / 35
页数:5
相关论文
共 34 条
[1]  
Jobe A.H., Bancalari E., Bronchopulmonary dysplasia, Am. J. Respir. Crit. Care Med., 163, pp. 1723-1729, (2001)
[2]  
Lemons J.A., Bauer C.R., Oh W., Et al., Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Resarch Network, January 1995 through December 1996, Pediatrics, 107, (2001)
[3]  
Hallman M., Haataja R., Genetic influences and neonatal lung disease, Semin. Neonatol., 8, pp. 19-27, (2003)
[4]  
Parker R.A., Lindstrom D.P., Cotton R.B., Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia, Semin. Perinatol., 20, pp. 206-209, (1996)
[5]  
Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A., Glutathione-S-transferase family of enzymes, Mutat. Res., 482, pp. 21-26, (2001)
[6]  
Salinas A.E., Wong M.G., Glutathione S-transferases - A review, Curr. Med. Chem., 6, pp. 279-309, (1999)
[7]  
Rushmore T.H., Pickett C.B., Glutathione S-transferases, structure, regulation, and therapeutic implications, J. Biol. Chem., 268, pp. 11475-11478, (1993)
[8]  
Rahman Q., Abidi P., Afaq F., Et al., Glutathione redox system in oxidative lung injury, Crit. Rev. Toxicol., 29, pp. 543-568, (1999)
[9]  
Fryer A.A., Bianco A., Hepple M., Et al., Polymorphism at the glutathione S-transferase GSTSP1 locus. A new marker from bronchial hyperresponsiveness and asthma, Am. J. Respir. Crit. Care Med., 161, pp. 1437-1442, (2000)
[10]  
Smith C.A., Harrison D.J., Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema, Lancet, 350, pp. 630-633, (1997)